Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Pasta

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Pediatrics|September 2, 2008
Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosisClement L Ren, David J Pasta, Lawrence Rasouliyan, et al.
Arthritis Care & Research|August 29, 2015
Alternative Methods for Defining Osteoarthritis and the Impact on Estimating Prevalence in a US Population-Based SurveyMiriam G Cisternas, Louise Murphy, Jeffrey J Sacks, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 14, 2011
Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sampleAlexandra L Quittner, Gregory S Sawicki, Ann McMullen, et al.
The Journal of Rheumatology|October 3, 2009
Trends in medical care expenditures of US adults with arthritis and other rheumatic conditions 1997 to 2005Miriam G Cisternas, Louise B Murphy, Edward H Yelin, et al.
The Journal of Pediatrics|January 18, 2023
Corrigendum to FEV1 Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function [The Journal of Pediatrics (2016) 116-121]Wayne J Morgan, Donald R VanDevanter, David J Pasta, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 16, 2014
Pulmonary function outcomes for assessing cystic fibrosis careJeffrey S Wagener, Eric P Elkin, David J Pasta, et al.
Pediatric Pulmonology|July 4, 2017
Comparison of FEV<sub>1</sub> reference equations for evaluating a cystic fibrosis therapeutic interventionMichael W Konstan, Jeffrey S Wagener, Donald R VanDevanter, et al.
Pediatric Pulmonology|November 21, 2019
Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosisJeffrey S Wagener, Donald R VanDevanter, Michael W Konstan, et al.
Pediatric Pulmonology|February 24, 2012
Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosisSusanna A McColley, Clement L Ren, Michael S Schechter, et al.
The Journal of Urology|December 13, 2006
Quality of life for men receiving a second treatment for prostate cancerShelley A Arredondo, David M Latini, Natalia Sadetsky, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Pediatrics|September 2, 2008
Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosisClement L Ren, David J Pasta, Lawrence Rasouliyan, et al.
Arthritis Care & Research|August 29, 2015
Alternative Methods for Defining Osteoarthritis and the Impact on Estimating Prevalence in a US Population-Based SurveyMiriam G Cisternas, Louise Murphy, Jeffrey J Sacks, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 14, 2011
Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sampleAlexandra L Quittner, Gregory S Sawicki, Ann McMullen, et al.
The Journal of Rheumatology|October 3, 2009
Trends in medical care expenditures of US adults with arthritis and other rheumatic conditions 1997 to 2005Miriam G Cisternas, Louise B Murphy, Edward H Yelin, et al.
The Journal of Pediatrics|January 18, 2023
Corrigendum to FEV1 Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function [The Journal of Pediatrics (2016) 116-121]Wayne J Morgan, Donald R VanDevanter, David J Pasta, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 16, 2014
Pulmonary function outcomes for assessing cystic fibrosis careJeffrey S Wagener, Eric P Elkin, David J Pasta, et al.
Pediatric Pulmonology|July 4, 2017
Comparison of FEV<sub>1</sub> reference equations for evaluating a cystic fibrosis therapeutic interventionMichael W Konstan, Jeffrey S Wagener, Donald R VanDevanter, et al.
Pediatric Pulmonology|November 21, 2019
Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosisJeffrey S Wagener, Donald R VanDevanter, Michael W Konstan, et al.
Pediatric Pulmonology|February 24, 2012
Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosisSusanna A McColley, Clement L Ren, Michael S Schechter, et al.
The Journal of Urology|December 13, 2006
Quality of life for men receiving a second treatment for prostate cancerShelley A Arredondo, David M Latini, Natalia Sadetsky, et al.
Pageof 10